Distinct membrane properties are differentially influenced by cardiolipin content and acyl chain composition in biomimetic membranes

仿生膜中心磷脂含量和酰基链组成对膜特性的影响各不相同。

阅读:3

Abstract

Cardiolipin (CL) has a critical role in maintaining mitochondrial inner membrane structure. In several conditions such as heart failure and aging, there is loss of CL content and remodeling of CL acyl chains, which are hypothesized to impair mitochondrial inner membrane biophysical organization. Therefore, this study discriminated how CL content and acyl chain composition influenced select properties of simple and complex mitochondrial mimicking model membranes. We focused on monolayer excess area/molecule (a measure of lipid miscibility), bilayer phase transitions, and microdomain organization. In monolayer compression studies, loss of tetralinoleoyl [(18:2)(4)] CL content decreased the excess area/molecule. Replacement of (18:2)(4)CL acyl chains with tetraoleoyl [(18:1)(4)] CL or tetradocosahexaenoyl [(22:6)(4)] CL generally had little influence on monolayer excess area/molecule; in contrast, replacement of (18:2)(4)CL acyl chains with tetramyristoyl [(14:0)(4)] CL increased monolayer excess area/molecule. In bilayers, calorimetric studies showed that substitution of (18:2)(4)CL with (18:1)(4)CL or (22:6)(4)CL lowered the phase transition temperature of phosphatidylcholine vesicles whereas (14:0)(4)CL had no effect. Finally, quantitative imaging of giant unilamellar vesicles revealed differential effects of CL content and acyl chain composition on microdomain organization, visualized with the fluorescent probe Texas Red DHPE. Notably, microdomain areas were decreased by differing magnitudes upon lowering of (18:2)(4)CL content and substitution of (18:2)(4)CL with (14:0)(4)CL or (22:6)(4)CL. Conversely, exchanging (18:2)(4)CL with (18:1)(4)CL increased microdomain area. Altogether, these data demonstrate that CL content and fatty acyl composition differentially target membrane physical properties, which has implications for understanding how CL regulates mitochondrial activity and the design of CL-specific therapeutics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。